• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX; SUPRARENAL AORTIC EXTENSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX; SUPRARENAL AORTIC EXTENSION Back to Search Results
Model Number A34-34/C100-O20
Device Problems Fracture (1260); Stretched (1601)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 09/10/2018
Event Type  Injury  
Manufacturer Narrative
The devices involved in the event will not be returned for evaluation, they remain implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event Description
Patient was initially implanted with a bifurcated and suprarenal stent graft in 2013.On (b)(6) 2018, the patient received a ct scan which showed dilation and fracture of the suprarenal cuff.The sac is stable and there was no evidence of an endoleak.Patient is currently doing well and will undergo diagnostic angiography.The physician is considering a reline, but a date has not been scheduled.As of this report, no additional patient sequelae has been reported.
 
Event Description
Additional information: a secondary procedure was completed.The physician elected to reline the original implanted devices with another bifurcated stent graft, and a suprarenal stent graft extension to resolve this event.It was reported that the patient did well.
 
Manufacturer Narrative
The manufacturing lot evaluation confirmed all devices met specifications prior to release.The device was not returned as the device remains implanted therefore no evaluation was completed.At the completion of the clinical assessment, due to the lack of relevant medical imaging, clinical was unable to find substantial evidence to support the following events of dilation and fracture of the proximal extension.Several attempts were made to obtain medical records and/or images from the medical center where the intervention was completed but no response was received.Procedure related harms, device, user, procedure or anatomy relatedness of this complaint could not be determined.The final patient status was reported to be well post successful secondary endovascular procedure.No additional investigation of this reported event is planned however if additional information pertinent to the incident is obtained, a follow-up report will be submitted.Endologix will continue to monitor this complaint and similar complaints in the event further investigation is needed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
SUPRARENAL AORTIC EXTENSION
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
MDR Report Key7985243
MDR Text Key124355684
Report Number2031527-2018-00785
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 09/20/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/30/2016
Device Model NumberA34-34/C100-O20
Device Lot Number1047244-019
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/20/2018
Initial Date FDA Received10/19/2018
Supplement Dates Manufacturer Received03/28/2019
Supplement Dates FDA Received03/30/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
AFX-BIFURCATED-LOT: 1111679-005; AFX-BIFURCATED-LOT: 1111679-005
Patient Outcome(s) Other; Required Intervention;
Patient Age68 YR
-
-